Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Perrone

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyC Gridelli, F Perrone, C Gallo, et al.
Oral Oncology|September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II studyL D Locati, P Bossi, F Perrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervixS Pignata, G Silvestro, E Ferrari, et al.
British Journal of Cancer|April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trialC Pacilio, A Morabito, F Nuzzo, et al.
Oncology|May 27, 1999
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancerR Lauria, E Ferrari, S Tramontana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyR Granata, R Miceli, E Orlandi, et al.
ESMO Open|June 4, 2023
Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical OncologyA G Leone, R Miceli, D Trapani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-IsoleC Gridelli, F Perrone, G P Ianniello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 24, 2022
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice GuidelineM Di Maio, E Basch, F Denis, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyC Gridelli, F Perrone, C Gallo, et al.
Oral Oncology|September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II studyL D Locati, P Bossi, F Perrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervixS Pignata, G Silvestro, E Ferrari, et al.
British Journal of Cancer|April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trialC Pacilio, A Morabito, F Nuzzo, et al.
Oncology|May 27, 1999
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancerR Lauria, E Ferrari, S Tramontana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyR Granata, R Miceli, E Orlandi, et al.
ESMO Open|June 4, 2023
Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical OncologyA G Leone, R Miceli, D Trapani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-IsoleC Gridelli, F Perrone, G P Ianniello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 24, 2022
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice GuidelineM Di Maio, E Basch, F Denis, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
Pageof 19